A detailed history of Bank Of America Corp transactions in En V Veno Medical Corp stock. As of the latest transaction made, Bank Of America Corp holds 99 shares of NVNO stock, worth $360. This represents 0.0% of its overall portfolio holdings.

Number of Shares
99
Holding current value
$360
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.62 - $5.5 $457 - $544
99 New
99 $0
Q4 2023

Feb 14, 2024

BUY
$3.46 - $5.73 $27 - $45
8 New
8 $0
Q4 2022

Feb 10, 2023

BUY
$4.54 - $6.6 $45 - $66
10 New
10 $0
Q1 2022

May 16, 2022

SELL
$4.42 - $7.0 $19,615 - $31,066
-4,438 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$6.23 - $10.24 $27,648 - $45,445
4,438 New
4,438 $29,000

Others Institutions Holding NVNO

About enVVeno Medical Corp


  • Ticker NVNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 9,469,850
  • Market Cap $34.5M
  • Description
  • enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...
More about NVNO
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.